We have isolated a variant human H2B core (GL105) histone gene and a variant Hl linker (CI110) histone cDNA. The H2B histone gene expresses alternative mRNAs regulated differentially during the HeLa cell cycle.. The H2B gene encodes both a 500 nt replication-dependent mRNA and a 2300 NT HHC89 constitutively expressed mRNA. The 3' end of the cell cycle regulated mRNA terminates immediately following the region of hyphenated dyad symmetry typical of most histone mRNAs, whereas the constitutively expressed HHC289 mRNA has a 1798 nt non-translated trailer that contains the same region of hyphenated dyad symmetry but is polyadenylated. Our results demonstrate that replication-dependent and constitutively expressed histone mRNAs can be encoded by the same gene and indicate that alternative 3' end processing is a major level of regulation by which cells can modulate the synthesis of variant histone proteins during the cell cycle and at the onset of differentiation. When Northern blot analysis was carried out we observed the 2300 nt expression of a second variant H2B gene. The H1 histone gene, like the H2B variant, contains a 3' region of hyphenated dyad symmetry and a polyaddenylation sequence. The regulation of this gene is now under investigation. The long-range objective of these studies is to understand the cellular mechanisms and signals, that modulate the expression and processing of RNA transcripts from the variant histone genes under different biological conditions. These studies will address the extent to which the expression of variant histone genes is modulated by the growth state of the cell. We will also examine the role specific nucleotide sequences play in the regulation and alternative processing of variant human histone mRNAs. The post-transcriptional regulation of variant human histone genes will be analyzed during changes in the proliferative state of the cell. These results will provide additional insight into eukaryotic gene expression growth regulation, differentiation, and carcinogenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Minority Biomedical Research Support - MBRS (S06)
Project #
5S06GM008247-13
Application #
6347543
Study Section
Minority Programs Review Committee (MPRC)
Project Start
2000-09-01
Project End
2001-08-31
Budget Start
Budget End
Support Year
13
Fiscal Year
2000
Total Cost
$69,492
Indirect Cost
Name
Clark Atlanta University
Department
Type
DUNS #
065325177
City
Atlanta
State
GA
Country
United States
Zip Code
30314
Ifere, Godwin O; Equan, Anita; Gordon, Kereen et al. (2010) Cholesterol and phytosterols differentially regulate the expression of caveolin 1 and a downstream prostate cell growth-suppressor gene. Cancer Epidemiol 34:461-71
Mariam, Yitbarek H; Musin, Ryza N (2008) Transition from moderate to strong hydrogen bonds: its identification and physical bases in the case of O-H...O intramolecular hydrogen bonds. J Phys Chem A 112:134-45
Kimbro, K Sean; Duschene, Kaitlin; Willard, Margeret et al. (2008) A novel gene STYK1/NOK is upregulated in estrogen receptor-alpha negative estrogen receptor-beta positive breast cancer cells following estrogen treatment. Mol Biol Rep 35:23-7
Chu, Qinghui; Pang, Yi (2004) Vibronic structures in the electronic spectra of oligo(phenylene ethynylene): effect of m-phenylene to the optical properties of poly(m-phenylene ethynylene). Spectrochim Acta A Mol Biomol Spectrosc 60:1459-67
Sannigrahi, Biswajit; McGeady, Paul; Khan, Ishrat M (2004) Helical poly(3-methyl-4-vinylpyridine)/amino acid complexes: preparation, characterization, and biocompatibility. Macromol Biosci 4:999-1007
Liang, Sidney; Bu, Xiu R (2002) Tertiary pentyl groups enhance salen titanium catalyst for highly enantioselective trimethylsilylcyanation of aldehydes. J Org Chem 67:2702-4
Vanderveer, Donald; Colon, Marisabel Lebron; Bu, Xiu R (2002) Crystal structure of a chiral Ni complex: (R,R)-N,N'-bis(3-t-butylsalicylidene)-1,2-cyclohexanediaminonickel(II). Anal Sci 18:1283-4
Musey, Paul I; Ibim, Sobrasua M; Talukder, Niranjan K (2002) Development of artificial blood vessels: seeding and proliferation characteristics of endothelial and smooth muscle cells on biodegradable membranes. Ann N Y Acad Sci 961:279-83
Chiang, C F; Okou, D T; Griffin, T B et al. (2001) Green fluorescent protein rendered susceptible to proteolysis: positions for protease-sensitive insertions. Arch Biochem Biophys 394:229-35
Johnson, K P; Rowe, G C; Jackson, B A et al. (2001) Novel antineoplastic isochalcones inhibit the expression of cyclooxygenase 1,2 and EGF in human prostate cancer cell line LNCaP. Cell Mol Biol (Noisy-le-grand) 47:1039-45

Showing the most recent 10 out of 17 publications